张鼎, 刘羽阳, 徐兴华, 张军. 前庭神经鞘瘤听力保留与重建技术研究进展[J]. 解放军医学院学报, 2023, 44(8): 918-921. DOI: 10.12435/j.issn.2095-5227.2023.032
引用本文: 张鼎, 刘羽阳, 徐兴华, 张军. 前庭神经鞘瘤听力保留与重建技术研究进展[J]. 解放军医学院学报, 2023, 44(8): 918-921. DOI: 10.12435/j.issn.2095-5227.2023.032
ZHANG Ding, LIU Yuyang, XU Xinghua, ZHANG Jun. Research advances in hearing preservation and reconstruction in vestibular schwannoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(8): 918-921. DOI: 10.12435/j.issn.2095-5227.2023.032
Citation: ZHANG Ding, LIU Yuyang, XU Xinghua, ZHANG Jun. Research advances in hearing preservation and reconstruction in vestibular schwannoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(8): 918-921. DOI: 10.12435/j.issn.2095-5227.2023.032

前庭神经鞘瘤听力保留与重建技术研究进展

Research advances in hearing preservation and reconstruction in vestibular schwannoma

  • 摘要: 近年来,前庭神经鞘瘤的外科治疗目标已由降低致死/致残率、提高面神经功能保留率发展到保留和重建听力,然而目前仅30% ~ 60%患者能够保留听力。前庭神经鞘瘤的治疗手段复杂多样,无论放射治疗、显微手术还是保守观察,都面临近、远期听力下降甚至单侧聋的结局。目前前庭神经鞘瘤听力保留及重建的相关研究较少,本文就该领域相关进展进行总结,以期促进前庭神经鞘瘤患者听力保留与听力重建研究工作的进展。

     

    Abstract: In recent years, the goal of surgical treatment of vestibular schwannoma has been developed from reducing the mortality and disability rate and improving the retention rate of facial nerve function to preserving and reconstructing hearing. However, it is reported that only about 30%-60% of patients can preserve hearing. The treatment methods of vestibular neurinoma are complex and diverse. No matter patients undergoing radiotherapy, microsurgery or conservative observation, all of them may face short-term and long-term hearing loss and even unilateral deafness. At present, there are relatively few studies on vestibular schwannoma hearing preservation and reconstruction. This article summarizes the relevant progress in this field, in order to promote the progress in the research on vestibular schwannoma hearing preservation and hearing reconstruction.

     

/

返回文章
返回